Hospital & IDN Key Account Manager — Carolinas

Viatris; Charleston (SC); On-site; USD 112,000 - 165,000; Full time

Job summary

Mylan Institutional Inc. in the Carolinas is seeking a Key Account Manager, Institutional Sales to manage NC and SC portfolios, including Generic Injectables and select brands across North America.

You will analyze sales data for 180+ injectable NDCs, optimize pricing and ensure contract eligibility, while collaborating with buyers and account teams to drive compliance and pull-through opportunities within a growing Viatris portfolio.

Qualifications

• Must possess knowledge of pharmaceutical or medical sales processes and procedures.
• Ability to travel up to 50% by vehicle and airplane.
• Proficiency in speaking, comprehending, reading and writing English is required.

Responsibilities

• Territories include North and South Carolina.
• Analyze sales data for portfolio of 180+ Injectable NDCs; manage pricing and contracts with hospitals, IDNs and GPOs.
• Drive compliance to GPO awards and back-up contracts to sell the whole portfolio of Viatris products.
• Track market conditions and communicate shortages to supply chain for forecast and demand planning.
• Maintain updated customer account profiles and contract information; ensure inventory is stocked for hospital purchases.
• Collaborate with sales, leadership and pricing teams across business units.
• Conduct account reviews and provide product information and pricing details as needed.
• Complete required paperwork and manage corporate resources and travel expenditures.

Skills

English proficiency

Travel 50%

Education

Four-year degree

Job description

Mylan Institutional Inc. in the Carolinas is seeking a Key Account Manager, Institutional Sales to manage NC and SC portfolios, including Generic Injectables and select brands across North America.

You will analyze sales data for 180+ injectable NDCs, optimize pricing and ensure contract eligibility, while collaborating with buyers and account teams to drive compliance and pull-through opportunities within a growing Viatris portfolio.